More SEC Filings
View Older Stories View Newer Stories-
Form SCHEDULE 13G Crinetics Pharmaceutical Filed by: VANGUARD CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G Core Natural Resources, Filed by: VANGUARD CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G CARVANA CO. Filed by: VANGUARD CAPITAL MANAGEMENT LLC
-
Form 4 Orchestra BioMed Holding For: Apr 27 Filed by: RTW INVESTMENTS, LP
-
Form 3 RRE Ventures Acquisition For: Apr 29 Filed by: Galpern Daniel H.
-
Form SCHEDULE 13G Chemours Co Filed by: VANGUARD CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G CONMED Corp Filed by: VANGUARD CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G Celldex Therapeutics, Filed by: VANGUARD CAPITAL MANAGEMENT LLC
-
Form 4 TEXAS CAPITAL BANCSHARES For: Apr 28 Filed by: Arbour Paola M
-
Form SCHEDULE 13G Champion Homes, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G Cboe Global Markets, Filed by: VANGUARD CAPITAL MANAGEMENT LLC
-
Form 3 SILVER BOW MINING CORP. For: Apr 29 Filed by: Holloway Andrew Richard
-
Form 3 RRE Ventures Acquisition For: Apr 29 Filed by: RRE Sponsor, LLC
-
Form 144 RADCOM LTD Filed by: Lynrock Lake Master Fund LP
-
Form 4 TEXAS CAPITAL BANCSHARES For: Apr 28 Filed by: Huntley David S.
-
Form 3 SILVER BOW MINING CORP. For: Apr 29 Filed by: McMullin David Daisel
-
Form 4 TEXAS CAPITAL BANCSHARES For: Apr 28 Filed by: Whitley Laura L
-
Form 3 RRE Ventures Acquisition For: Apr 29 Filed by: Epstein Jeffrey Douglas
-
Form 3 SILVER BOW MINING CORP. For: Apr 29 Filed by: Durbin Steven Douglas Jr
-
Form 4 TEXAS CAPITAL BANCSHARES For: Apr 28 Filed by: Midkiff Mark W
-
Form 3 SILVER BOW MINING CORP. For: Apr 29 Filed by: HENNIGH QUINTON TODD
-
Form SCHEDULE 13G Janux Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form PRER14A Quantum Computing Inc.
-
Form 4 TEXAS CAPITAL BANCSHARES For: Apr 28 Filed by: Tremblay Dale W
-
Form 4 HERSHEY CO For: Apr 27 Filed by: HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL
-
Form 3 SILVER BOW MINING CORP. For: Apr 29 Filed by: Naugle Charles Travis
-
Form DEFA14A HANMI FINANCIAL CORP
-
Form 424B3 Flat Rock Opportunity
-
Form SCHEDULE 13G Janux Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 8-K Profusa, Inc. For: Apr 24
-
Form 3 RRE Ventures Acquisition For: Apr 29 Filed by: KUCHARCHUK ANDREW ALBERT
-
Form 4 TEXAS CAPITAL BANCSHARES For: Apr 28 Filed by: Long Thomas E
-
Form 3 RRE Ventures Acquisition For: Apr 29 Filed by: Ellman Stuart J.
-
Form 3 RRE Ventures Acquisition For: Apr 29 Filed by: Kassin Philip (Phil)
-
Form 3 RRE Ventures Acquisition For: Apr 29 Filed by: Bernstein Bruce
-
Form 3 RRE Ventures Acquisition For: Apr 29 Filed by: Mancini Robert Scott
-
Form 3 RRE Ventures Acquisition For: Apr 29 Filed by: Daly Brian Frederick
-
Form 424B3 Cadrenal Therapeutics,
-
Form FWP CANADIAN IMPERIAL BANK Filed by: CANADIAN IMPERIAL BANK OF COMMERCE /CAN/
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 486APOS Flat Rock Opportunity
-
Form 6-K Inter & Co, Inc. For: Apr 29
-
Form 486APOS Flat Rock Enhanced Incom
-
Form 20-F COMPANHIA DE SANEAMENTO For: Dec 31
-
Form 486APOS Flat Rock Core Income
-
Form 10-K/A Identiv, Inc. For: Dec 31
-
Form POS AM Glucotrack, Inc.
-
Form 424B5 Intellia Therapeutics,

